China's Former Drug Registration Chief Gets Suspended Death Sentence (China)
This article was originally published in PharmAsia News
Executive Summary
Former State Food and Drug Administration drug registration chief Cao Wenzhuang received a suspended death sentence for seeking "benefits" from two pharmaceutical companies in exchange for approving their drug and medical equipment applications. He will serve seven years in prison, lose all property he possesses, and his sentence of death includes a two-year reprieve. He led the division from 2003 to 2005. (Click here for more
You may also be interested in...
Investors Go Beserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.